{"meta":{"query_hash":"dcb8de39aacb","filters":{"venue":"Degenerative Neurological and Neuromuscular Disease"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/dcb8de39aacb","api":"https://metacan.xera.ac/api/v1/cohort?venue=Degenerative+Neurological+and+Neuromuscular+Disease"},"results":[{"id":"W1859536052","doi":"10.2147/dnnd.s48420","title":"Current and emerging treatment options for spinal muscular atrophy","year":2015,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Spinal muscular atrophy; Medicine; Current (fluid); Physical medicine and rehabilitation; Atrophy; Neuroscience; Pathology; Psychology; Disease; Engineering","score_opus":0.1445036446927771,"score_gpt":0.41938417288108176,"score_spread":0.27488052818830466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1859536052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00887613,0.98590904,0.0002309621,0.00049230846,0.00017913705,0.0039916085,0.00023845184,0.00006830115,0.000014052017],"genre_scores_gemma":[0.00023373011,0.996864,0.00019595624,0.0002664729,0.00036559533,0.0015232981,0.00034247822,0.00009297972,0.0001154459],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640304,0.0006132188,0.00050704234,0.0014440718,0.00044619478,0.0005864188],"domain_scores_gemma":[0.9976629,0.000099973324,0.00012965554,0.00052725535,0.0001733319,0.0014068999],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017911496,0.00079344504,0.0017272945,0.0002518117,0.00030917814,0.000088091154,0.00013948933,0.00018489119,0.000024993229],"category_scores_gemma":[0.00027788276,0.0005224801,0.0010451763,0.000261335,0.00034183517,0.0000487527,0.00021707367,0.0004369857,0.000013333632],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036617875,0.0006045647,0.00007932622,0.0054682535,0.0002421559,0.00051099394,0.0000113536325,0.0000034382826,0.000011163252,0.00051493535,0.00023051056,0.9919571],"study_design_scores_gemma":[0.0014237956,0.003562144,0.000609473,0.0005592028,0.0036228332,0.0001482513,0.0000025873267,0.00031936262,0.000001423141,0.00012744467,0.98919785,0.00042560525],"about_ca_topic_score_codex":0.0000018067112,"about_ca_topic_score_gemma":7.484916e-7,"teacher_disagreement_score":0.9915315,"about_ca_system_score_codex":0.00003701398,"about_ca_system_score_gemma":0.00039778868,"threshold_uncertainty_score":0.99972266},"labels":[],"label_agreement":null},{"id":"W2023509561","doi":"10.2147/dnnd.s40349","title":"Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA","year":2014,"lang":"en","type":"article","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Overactive bladder; Spinal cord injury; Medicine; Multiple sclerosis; Spinal cord; Urology; Pathology; Psychiatry","score_opus":0.035313223653624985,"score_gpt":0.2870808102207711,"score_spread":0.2517675865671461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023509561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963256,0.0019652925,0.000016153348,0.00094232714,0.00003243216,0.00054211833,0.000047028298,0.00002657714,0.00010248519],"genre_scores_gemma":[0.9970925,0.001213382,0.00006345498,0.0014567499,0.0000686536,0.000039688963,0.000015308717,0.000022378628,0.000027903237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787515,0.00053762435,0.00028348624,0.00065156154,0.0003085851,0.0003435842],"domain_scores_gemma":[0.9989108,0.0001857938,0.000062566876,0.00025059748,0.00008215496,0.0005080864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017693815,0.00024937448,0.00039800038,0.00013877738,0.00009664497,0.000025583804,0.00008193597,0.00007891492,0.000046750327],"category_scores_gemma":[0.0005458152,0.00019325671,0.00011140554,0.00022078337,0.0003131253,0.00011078072,0.00018386397,0.00041222133,0.0000050670947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051038872,0.0024668355,0.47361657,0.00026113863,0.00014621645,0.00084186543,0.00014453952,0.000044919296,0.379232,0.0012740777,0.00011050176,0.09082247],"study_design_scores_gemma":[0.0016093985,0.008533984,0.97729206,0.00002867653,0.000086442145,0.00003683786,0.000014251846,0.0046269083,0.0060581355,0.0005107248,0.0010283638,0.00017421044],"about_ca_topic_score_codex":0.000014526574,"about_ca_topic_score_gemma":0.0000032640964,"teacher_disagreement_score":0.5036755,"about_ca_system_score_codex":0.0000057708867,"about_ca_system_score_gemma":0.000049418257,"threshold_uncertainty_score":0.788078},"labels":[],"label_agreement":null},{"id":"W2035586497","doi":"10.2147/dnnd.s34160","title":"The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration","year":2013,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Neuroscience; Affect (linguistics); Pathophysiology; Psychology; Medicine; Neuroimaging; Psychiatry; Internal medicine","score_opus":0.06466464101282918,"score_gpt":0.3086984988233055,"score_spread":0.24403385781047635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035586497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36804065,0.6293806,0.000016331935,0.00059745554,0.00015163119,0.0015825386,0.00018044625,0.000042282223,0.000008100363],"genre_scores_gemma":[0.023814788,0.97323436,0.000037353093,0.001829002,0.0001552507,0.0006787066,0.000031317228,0.00007539629,0.00014382656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9879897,0.008167954,0.0008632063,0.0019160646,0.0003745158,0.000688534],"domain_scores_gemma":[0.9921929,0.005630821,0.00089041056,0.0005168799,0.0001495174,0.0006194538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004713604,0.00089795946,0.0017969878,0.00013769323,0.00069525,0.000115979004,0.00034097602,0.0003017898,0.00001519713],"category_scores_gemma":[0.0075308327,0.00049683027,0.00029227705,0.0003240812,0.00074015267,0.00015062117,0.00045289347,0.00066125824,0.000011990592],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013959149,0.0013464054,0.0051101902,0.0140581215,0.00057071936,0.0007469149,0.00014295777,0.00045796836,0.08408601,0.04165209,0.002305726,0.848127],"study_design_scores_gemma":[0.0078765275,0.027988598,0.10129815,0.003697991,0.017539572,0.000996896,0.000030268175,0.021224644,0.050279953,0.012486335,0.74495906,0.011622011],"about_ca_topic_score_codex":0.0000020339319,"about_ca_topic_score_gemma":0.000001936281,"teacher_disagreement_score":0.836505,"about_ca_system_score_codex":0.000016213002,"about_ca_system_score_gemma":0.00012331046,"threshold_uncertainty_score":0.99974835},"labels":[],"label_agreement":null},{"id":"W2044209898","doi":"10.2147/dnnd.s70079","title":"Use of transcranial magnetic stimulation in the treatment of selected movement disorders","year":2014,"lang":"en","type":"article","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transcranial magnetic stimulation; Physical medicine and rehabilitation; Movement disorders; Medicine; Stimulation; Movement (music); Neuroscience; Psychology; Internal medicine; Physics","score_opus":0.04214995891808099,"score_gpt":0.24891529098497003,"score_spread":0.20676533206688905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044209898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736136,0.00015881356,0.0005785071,0.0010514134,0.00004692828,0.000721791,0.000040467163,0.000018925091,0.000021787748],"genre_scores_gemma":[0.9983841,0.00046411448,0.00006113504,0.0009860572,0.00002110283,0.00006112213,0.0000036520034,0.000009187235,0.000009535523],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978747,0.00092030835,0.0003233845,0.00041045225,0.00029410407,0.0001770855],"domain_scores_gemma":[0.99869525,0.00092672097,0.00006938976,0.00019561,0.000037742833,0.00007528164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060879793,0.00019345926,0.00025795551,0.00007703476,0.00008509222,0.000018665158,0.00010373426,0.00003415114,0.000032359723],"category_scores_gemma":[0.00045142596,0.00012035335,0.00010113676,0.0003803526,0.00028447862,0.000064243744,0.000012138406,0.00006316959,8.912434e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026819927,0.004390865,0.118263304,0.00006697371,0.0000139644935,0.000042232816,0.0015402917,0.031412095,0.8080452,0.0073933173,0.000017226037,0.026132539],"study_design_scores_gemma":[0.0014542713,0.0041508963,0.9598808,0.0000037936193,0.00006776116,4.7265632e-7,0.0000032748535,0.030175865,0.002759177,0.00091142365,0.00048050637,0.00011172853],"about_ca_topic_score_codex":0.000019494631,"about_ca_topic_score_gemma":0.000023336714,"teacher_disagreement_score":0.8416175,"about_ca_system_score_codex":0.0000033646772,"about_ca_system_score_gemma":0.000010172422,"threshold_uncertainty_score":0.4907867},"labels":[],"label_agreement":null},{"id":"W2555671962","doi":"10.2147/dnnd.s87323","title":"Respiratory management of patients with neuromuscular disease: current perspectives","year":2016,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Neuromuscular disease; Weakness; Medicine; Respiratory failure; Respiratory system; Intensive care medicine; Disease; Muscle weakness; Physical medicine and rehabilitation; Physical therapy; Internal medicine; Surgery","score_opus":0.032804646879167086,"score_gpt":0.3002633819016569,"score_spread":0.26745873502248985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555671962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043475043,0.95290226,0.000039449176,0.00016454227,0.00014999277,0.0025261282,0.000618712,0.00007356533,0.00005030768],"genre_scores_gemma":[0.0033035115,0.9953987,0.000034170982,0.00029965784,0.00018982976,0.00036316604,0.00018747004,0.000115103554,0.000108388725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99551576,0.0007953559,0.0007031734,0.0016339924,0.00084627455,0.00050546293],"domain_scores_gemma":[0.99711215,0.00010686653,0.00036391997,0.00097443047,0.00023402403,0.001208578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012486562,0.00093624427,0.0018271342,0.00023831436,0.00016532243,0.000039861883,0.00027973452,0.00013006409,0.00016042532],"category_scores_gemma":[0.00011786177,0.00049976987,0.0009236956,0.00034487562,0.0005193698,0.0000877617,0.00033375164,0.00050747197,0.000026665652],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026673474,0.003724496,0.007280479,0.028090065,0.0011738255,0.0046764603,0.00002965239,0.0000012109195,0.0000023316063,0.0073675644,0.00035747944,0.9446291],"study_design_scores_gemma":[0.0016383796,0.0013172561,0.16115266,0.0046917177,0.0043868073,0.000006697504,0.0000025907812,0.000004337005,6.2401966e-7,0.000062803134,0.82614243,0.00059370283],"about_ca_topic_score_codex":2.1210592e-7,"about_ca_topic_score_gemma":7.9494065e-8,"teacher_disagreement_score":0.9440354,"about_ca_system_score_codex":0.000026234371,"about_ca_system_score_gemma":0.00016046624,"threshold_uncertainty_score":0.99974537},"labels":[],"label_agreement":null},{"id":"W2599002181","doi":"10.2147/dnnd.s71986","title":"Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a","year":2017,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cameco (Canada); Innovation Cluster (Canada); University of Saskatchewan","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada; Saskatchewan Health Research Foundation","keywords":"Multiple sclerosis; Medicine; PEGylation; Neuroinflammation; Pegylated interferon; Neurodegeneration; Interferon beta-1b; Immunology; Clinical trial; Pharmacology; Disease; Internal medicine; Interferon beta; Polyethylene glycol; Ribavirin; Biology; Hepatitis C virus","score_opus":0.22598482052524857,"score_gpt":0.3864206091049136,"score_spread":0.16043578857966503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599002181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060974028,0.93589664,0.0000064090905,0.00039891186,0.00008550099,0.0023328494,0.00017507574,0.00002138728,0.000109194836],"genre_scores_gemma":[0.054848656,0.9441502,0.000048192276,0.00011263447,0.00013934403,0.0005102535,0.00010414798,0.000037293652,0.0000492743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953178,0.0019373209,0.00087137386,0.0008372967,0.0005858137,0.00045039778],"domain_scores_gemma":[0.99650156,0.0014374916,0.0005933678,0.0010899765,0.00015145131,0.00022617712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004414288,0.00062605384,0.0019701512,0.0001584297,0.0003707229,0.000054787004,0.0005066623,0.00017076457,0.000023369688],"category_scores_gemma":[0.001824032,0.00027424475,0.00086167443,0.00026851904,0.0009381993,0.000093197596,0.0002419034,0.00059371896,0.0000064330147],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008579412,0.001424093,0.0039149383,0.002388079,0.0002254316,0.0000651991,0.00046855313,0.00001302557,0.00044622354,0.00003254286,0.00005497512,0.990109],"study_design_scores_gemma":[0.0011643546,0.002077954,0.018571738,0.0033344508,0.0012044237,0.000015869402,0.000033484946,0.00018049715,0.000043343498,0.000025421828,0.97307485,0.0002736029],"about_ca_topic_score_codex":0.0000244125,"about_ca_topic_score_gemma":0.00006525791,"teacher_disagreement_score":0.9898354,"about_ca_system_score_codex":0.00002966184,"about_ca_system_score_gemma":0.00010514987,"threshold_uncertainty_score":0.999971},"labels":[],"label_agreement":null},{"id":"W2884841728","doi":"10.2147/dnnd.s146949","title":"Physical therapy for individuals with amyotrophic lateral sclerosis: current insights","year":2018,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Amyotrophic lateral sclerosis; Life expectancy; Medicine; Disease; Quality of life (healthcare); Health care; Occupational therapy; Rehabilitation; Physical disability; Physical therapy; Physical medicine and rehabilitation; Nursing","score_opus":0.10671201332363073,"score_gpt":0.35023809143367735,"score_spread":0.24352607811004662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884841728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24486624,0.7507855,0.000020701744,0.00030113032,0.00011558909,0.003588239,0.00021930184,0.00009700598,0.0000062739864],"genre_scores_gemma":[0.006643238,0.988312,0.00009339406,0.0009615764,0.0013911108,0.001972794,0.0004058308,0.00014352424,0.00007653593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952425,0.00090314425,0.00054344465,0.001767902,0.00077939266,0.0007636555],"domain_scores_gemma":[0.9974363,0.000266825,0.0002323866,0.000683272,0.00023615996,0.0011450811],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013298274,0.0010218876,0.002219515,0.00021998271,0.00036293027,0.00017008248,0.00034138016,0.00025529863,0.000048527723],"category_scores_gemma":[0.00018273266,0.00052150676,0.00093815086,0.00042826904,0.0007373502,0.00012562155,0.0002629021,0.00092840503,0.00004430378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036443972,0.0040218947,0.0011380491,0.011481695,0.0012583892,0.0007923183,0.00014341187,0.000004184013,0.00016325236,0.00072317687,0.0021716703,0.97445756],"study_design_scores_gemma":[0.0024984542,0.007046928,0.014826375,0.0030726893,0.001603594,0.00004555635,4.1721273e-7,0.00023673203,0.00001174195,0.00021806873,0.969668,0.0007714644],"about_ca_topic_score_codex":0.0000010505587,"about_ca_topic_score_gemma":4.4008505e-7,"teacher_disagreement_score":0.9736861,"about_ca_system_score_codex":0.00003152464,"about_ca_system_score_gemma":0.00029600956,"threshold_uncertainty_score":0.9997237},"labels":[],"label_agreement":null},{"id":"W2953698201","doi":"10.2147/dnnd.s208815","title":"<p>Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials</p>","year":2019,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Randomized controlled trial; Intensive care medicine; Internal medicine; Psychiatry; Nursing","score_opus":0.17989305505061057,"score_gpt":0.3930955866060155,"score_spread":0.21320253155540494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953698201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013429966,0.9509493,0.00003015635,0.00045262885,0.00013018766,0.017723436,0.01724197,0.000021751785,0.000020592552],"genre_scores_gemma":[0.0025710822,0.99352825,0.00032358602,0.00027855719,0.00012424258,0.0012185869,0.0017947083,0.00006118817,0.00009982335],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9802069,0.010954181,0.006034934,0.001341017,0.001054728,0.00040823454],"domain_scores_gemma":[0.9628168,0.030025424,0.0045803133,0.0009964748,0.0009866,0.0005944126],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0045403596,0.0010237461,0.025722744,0.0003275516,0.000098101955,0.00002208385,0.00030985527,0.0003922184,0.000025600079],"category_scores_gemma":[0.116554454,0.00053270697,0.005914974,0.000453528,0.00096293015,0.000077920195,0.00037262822,0.00042121502,9.021424e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76141983,0.0027173439,0.00007243927,0.13282035,0.022881517,0.000054250522,0.00012378013,0.000004544365,0.0057749236,0.00028956725,0.00062302646,0.073218405],"study_design_scores_gemma":[0.6971099,0.0045365174,0.007980892,0.17005232,0.08698828,0.0000056774347,0.0000036465242,0.00036422405,0.00020447992,0.000030252564,0.03182366,0.000900191],"about_ca_topic_score_codex":0.000006659689,"about_ca_topic_score_gemma":0.0000020093655,"teacher_disagreement_score":0.11201409,"about_ca_system_score_codex":0.000015976928,"about_ca_system_score_gemma":0.0003299589,"threshold_uncertainty_score":0.99971247},"labels":[],"label_agreement":null},{"id":"W2980119243","doi":"10.2147/dnnd.s180027","title":"<p>Orphan Drugs In Development For The Treatment Of Friedreich’s Ataxia: Focus On Omaveloxolone</p>","year":2019,"lang":"en","type":"article","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Ataxia; Idebenone; Oxidative stress; Frataxin; Medicine; Pharmacology; Neuroscience; Internal medicine; Biology; Psychiatry; Iron-binding proteins","score_opus":0.01133972049844709,"score_gpt":0.2305556228567245,"score_spread":0.21921590235827743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980119243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930505,0.0046182913,0.00005611177,0.00093451544,0.0001545304,0.0010692504,0.00005653227,0.000009803357,0.00005047455],"genre_scores_gemma":[0.9970631,0.0014047414,0.000055047705,0.0006686232,0.00012131839,0.0003487676,0.000056077693,0.000021111333,0.00026122236],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99842024,0.00017699928,0.00024868862,0.0006599792,0.0001672044,0.00032687522],"domain_scores_gemma":[0.9992201,0.00015782155,0.00007678751,0.00034436828,0.000050814855,0.00015014241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108824286,0.00030352993,0.0003099358,0.00004019636,0.00015830879,0.000018543005,0.0001486813,0.0000886559,0.000015477233],"category_scores_gemma":[0.0000924273,0.00018445002,0.00018510001,0.00009290872,0.000114176175,0.00000392345,0.00011168453,0.00006163358,0.000007696835],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0124765225,0.004398401,0.04854539,0.00021306443,0.0006713633,0.0002142105,0.00086794974,0.0018847109,0.8922206,0.0040272353,0.0076932916,0.026787259],"study_design_scores_gemma":[0.0052432455,0.011985341,0.5325157,0.000025916905,0.00015704865,0.0000070435644,0.000020497442,0.001521949,0.16108032,0.000128913,0.28662524,0.0006888099],"about_ca_topic_score_codex":0.0000022151846,"about_ca_topic_score_gemma":0.000034505796,"teacher_disagreement_score":0.7311403,"about_ca_system_score_codex":0.000010901495,"about_ca_system_score_gemma":0.00004395894,"threshold_uncertainty_score":0.7521653},"labels":[],"label_agreement":null},{"id":"W4409365773","doi":"10.2147/dnnd.s495536","title":"Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies","year":2025,"lang":"en","type":"review","venue":"Degenerative Neurological and Neuromuscular Disease","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Genome editing; Muscular dystrophy; Medicine; Computer science; Computational biology; Gene; Biology; CRISPR; Genetics; Internal medicine","score_opus":0.031093457627698287,"score_gpt":0.33194634593768285,"score_spread":0.3008528883099846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409365773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030466331,0.95100415,0.015816119,0.00011235062,0.0004049305,0.0013520196,0.0007932438,0.00004161737,0.000009259749],"genre_scores_gemma":[0.008572847,0.984258,0.0021366256,0.000981334,0.0013524129,0.001290347,0.0011865052,0.00009910712,0.00012284677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973239,0.00024500286,0.00043118477,0.0013740688,0.0001763767,0.00044950697],"domain_scores_gemma":[0.9988356,0.0000788827,0.00009301048,0.0005073123,0.000070033806,0.0004151129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009120735,0.00068430975,0.0009029832,0.00010571076,0.00022063481,0.00008742312,0.00031891064,0.00024447715,0.00001306336],"category_scores_gemma":[0.00016987039,0.00055905135,0.00069246173,0.0001362036,0.00006941044,0.000007746588,0.00040004653,0.0002049202,0.0000023182986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011897152,0.0012420996,0.00004288654,0.009894799,0.002507398,0.00064388814,0.00034043944,0.017275346,0.1235574,0.0009713546,0.0044753347,0.83785933],"study_design_scores_gemma":[0.0007901982,0.0009881951,0.00005400549,0.00071968953,0.0011339547,0.000011791034,0.000020824902,0.0017022821,0.007285572,0.00016187668,0.98585427,0.0012773159],"about_ca_topic_score_codex":0.0000044562157,"about_ca_topic_score_gemma":0.0000014791337,"teacher_disagreement_score":0.981379,"about_ca_system_score_codex":0.000009026277,"about_ca_system_score_gemma":0.000074749085,"threshold_uncertainty_score":0.9996861},"labels":[],"label_agreement":null}]}